Axitinib effective as a third-line treatment for kidney cancer
A recent study published in the journal In Vivo assessed [...]
Promising efficacy and safety of seleno-L-methionine plus axitinib in advanced kidney cancer
Data from a recent phase I study of seleno-L-methionine in [...]
Evidence in favour of active surveillance for small renal masses
Two studies presented at the American Urological Association 2020 Virtual [...]
NHS reveals plans to increase hospital services
NHS England have issued a plan for re-instating urgent and [...]
Challenges of early detection of renal cell carcinoma
The incidence of kidney cancer in the UK has risen [...]
Ilixadencel granted Regenerative Medicine Advanced Therapy by FDA for metastatic kidney cancer
The US Food and Drug Administration (FDA) has designated ilixadencel [...]
Phase 1 trial of vorolanib plus everolimus for advanced kidney cancer
A new combination of vorolanib, a tyrosine kinase inhibitor plus [...]
Patients with cancer seem more vulnerable to COVID-19
A study conducted at Wuhan Hospital in China has shown [...]
Impact of lymph-node positive kidney cancer on survival
A recent study published in the journal Cancer last month [...]
Patient-reported outcomes with atezolizumab plus bevacizumab in metastatic kidney cancer
This study describes patient-reported outcomes from the phase 3 IMmotion151 [...]
